Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
3,436,549
-
Share change
-
+391,601
-
Total reported value
-
$709,821,098
-
Put/Call ratio
-
41%
-
Price per share
-
$206.52
-
Number of holders
-
274
-
Value change
-
+$83,086,713
-
Number of buys
-
116
-
Number of sells
-
100
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2025
As of 31 Dec 2025,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,436,549 shares.
The largest 10 holders included
MORGAN STANLEY, LPL Financial LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, UBS Group AG, ROYAL BANK OF CANADA, RAYMOND JAMES FINANCIAL INC, Berger Financial Group, Inc, ENVESTNET ASSET MANAGEMENT INC, and 360 Financial, Inc..
This page lists
274
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.